|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date25 Jan 2022 |
100 Clinical Results associated with Immunocore Ireland Ltd.
0 Patents (Medical) associated with Immunocore Ireland Ltd.
100 Deals associated with Immunocore Ireland Ltd.
100 Translational Medicine associated with Immunocore Ireland Ltd.